FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 44 filers reported holding FLEXION THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $974,000 | +19.7% | 40,280 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $814,000 | -6.2% | 40,280 | +24.9% | 0.00% | 0.0% |
| Q1 2017 | $868,000 | +38.9% | 32,254 | -1.8% | 0.00% | 0.0% |
| Q4 2016 | $625,000 | -3.3% | 32,854 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $646,000 | +48.5% | 33,035 | +13.5% | 0.00% | +50.0% |
| Q2 2016 | $435,000 | +85.9% | 29,095 | +14.4% | 0.00% | +100.0% |
| Q1 2016 | $234,000 | -51.2% | 25,435 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $480,000 | +29.7% | 24,928 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $370,000 | +27.6% | 24,928 | +88.2% | 0.00% | +100.0% |
| Q2 2015 | $290,000 | +187.1% | 13,248 | +196.3% | 0.00% | – |
| Q1 2015 | $101,000 | +16.1% | 4,471 | +4.1% | 0.00% | – |
| Q4 2014 | $87,000 | +33.8% | 4,296 | +20.8% | 0.00% | – |
| Q3 2014 | $65,000 | -50.8% | 3,556 | -63.6% | 0.00% | -100.0% |
| Q2 2014 | $132,000 | -59.3% | 9,756 | -50.4% | 0.00% | 0.0% |
| Q1 2014 | $324,000 | – | 19,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |